Literature DB >> 15996654

Pregnenolone sulfate acts through a G-protein-coupled sigma1-like receptor to enhance short term facilitation in adult hippocampal neurons.

Adrian R Schiess1, L Donald Partridge.   

Abstract

Neurosteroids have been linked to cognitive performance, and their levels are altered in neuropsychiatric diseases. These neuromodulators are produced in the brain where they have important effects on synaptic transmission at postsynaptic gamma-amino-butyric acid receptors and N-methyl-D-aspartate receptors and at presynaptic sites. We previously found, in cultured neonatal hippocampal neurons, that the neurosteroid, pregnenolone sulfate, acts presynaptically through a sigma1-like receptor to modulate basal glutamate release. The present study was designed to test whether pregnenolone sulfate acts through a similar presynaptic receptor in adult hippocampal neurons. The sigma1-receptor agonist, 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate, enhanced paired-pulse facilitation (PPF) by a similar extent to that which we had previously reported for pregnenolone sulfate. The sigma1-receptor antagonists, 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine and 1[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine, blocked the pregnenolone sulfate enhancement of PPF as did pretreatment of slices in pertussis toxin. We conclude that pregnenolone sulfate acts through a Gi/o-coupled sigma1-like receptor to enhance short-term presynaptic facilitation onto adult hippocampal CA1 neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996654     DOI: 10.1016/j.ejphar.2005.06.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Allosteric modulation of ATP-gated P2X receptor channels.

Authors:  Claudio Coddou; Stanko S Stojilkovic; J Pablo Huidobro-Toro
Journal:  Rev Neurosci       Date:  2011-03-16       Impact factor: 4.353

2.  Neurosteroid-induced enhancement of short-term facilitation involves a component downstream from presynaptic calcium in hippocampal slices.

Authors:  Adrian R B Schiess; Chessa S Scullin; L Donald Partridge
Journal:  J Physiol       Date:  2006-08-24       Impact factor: 5.182

3.  Facilitated glutamate release at Schaffer collateral to CA1 synapses has access to an exclusive population of NMDA receptors.

Authors:  Chessa S Scullin; Adrian R B Schiess; L Donald Partridge
Journal:  Brain Res       Date:  2015-06-20       Impact factor: 3.252

4.  Pregnenolone sulfate increases glutamate release at neonatal climbing fiber-to-Purkinje cell synapses.

Authors:  P A Zamudio-Bulcock; C F Valenzuela
Journal:  Neuroscience       Date:  2010-12-03       Impact factor: 3.590

5.  Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons.

Authors:  Taketoshi Kajimoto; Taro Okada; Huan Yu; Sravan K Goparaju; Saleem Jahangeer; Shun-ichi Nakamura
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

Review 6.  Modulation of glutamatergic transmission by sulfated steroids: role in fetal alcohol spectrum disorder.

Authors:  C Fernando Valenzuela; L Donald Partridge; Manuel Mameli; Douglas A Meyer
Journal:  Brain Res Rev       Date:  2007-05-03

7.  A Role for Sigma Receptors in Stimulant Self Administration and Addiction.

Authors:  Jonathan L Katz; Tsung-Ping Su; Takato Hiranita; Teruo Hayashi; Gianluigi Tanda; Theresa Kopajtic; Shang-Yi Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2011

8.  Regulation of neurosteroid biosynthesis by neurotransmitters and neuropeptides.

Authors:  Jean Luc Do Rego; Jae Young Seong; Delphine Burel; Jerôme Leprince; David Vaudry; Van Luu-The; Marie-Christine Tonon; Kazuyoshi Tsutsui; Georges Pelletier; Hubert Vaudry
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-24       Impact factor: 5.555

9.  Oxidative Stress-Mediated Brain Dehydroepiandrosterone (DHEA) Formation in Alzheimer's Disease Diagnosis.

Authors:  Georges Rammouz; Laurent Lecanu; Vassilios Papadopoulos
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-08       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.